跳转至内容
Merck
CN
  • SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis.

SMRT repression of nuclear receptors controls the adipogenic set point and metabolic homeostasis.

Proceedings of the National Academy of Sciences of the United States of America (2008-12-11)
Russell R Nofsinger, Pingping Li, Suk-Hyun Hong, Johan W Jonker, Grant D Barish, Hao Ying, Sheue-Yann Cheng, Mathias Leblanc, Wei Xu, Liming Pei, Yeon-Joo Kang, Michael Nelson, Michael Downes, Ruth T Yu, Jerrold M Olefsky, Chih-Hao Lee, Ronald M Evans
摘要

The nuclear receptor corepressor, silencing mediator of retinoid and thyroid hormone receptors (SMRT), is recruited by a plethora of transcription factors to mediate lineage and signal-dependent transcriptional repression. We generated a knockin mutation in the receptor interaction domain (RID) of SMRT (SMRT(mRID)) that solely disrupts its interaction with nuclear hormone receptors (NHRs). SMRT(mRID) mice are viable and exhibit no gross developmental abnormalities, demonstrating that the reported lethality of SMRT knockouts is determined by non-NHR transcription factors. However, SMRT(mRID) mice exhibit widespread metabolic defects including reduced respiration, altered insulin sensitivity, and 70% increased adiposity. The latter phenotype is illustrated by the observation that SMRT(mRID)-derived MEFs display a dramatically increased adipogenic capacity and accelerated differentiation rate. Collectively, our results demonstrate that SMRT-RID-dependent repression is a key determinant of the adipogenic set point as well as an integrator of glucose metabolism and whole-body metabolic homeostasis.